DR.REDDY'S LABORATORIES LTD. - 500124 - Grant Of Employee Stock Options
Grant of Employee Stock options06-05-2024
06-05-2024
Dr Reddy'slaunches Doxycycline capsules in the US
The drug is atherapeutic generic equivalent of ORACEA (doxycycline, USP) capsules03-05-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of share certificate(s)03-05-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201530-04-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Change in Management
Intimation under Regulation 3025-04-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Intimation Under Regulation 30
Intimation under Regulation 3025-04-2024
Dr. Reddy's Laboratories recalls sapropterin dihydrochloride oral solution powder
Dr Reddy's Laboratories recalls oral solution powder over fears of reduced potency, associated health risks24-04-2024
Dr Reddy's Recalls Six Lots Of Drug In US Due To Subpotency
The issue was discovered during an accelerated stability test in addition to customer complaints.23-04-2024